Literature DB >> 11563882

Inflammatory cytokines and soluble receptors after coronary artery bypass grafting.

M Wei1, P Kuukasjärvi, J Laurikka, E Pehkonen, S Kaukinen, S Laine, M Tarkka.   

Abstract

Much interest has been focused on the overexpression of proinflammatory cytokines, but studies on their soluble receptors are rare. For a comprehensive picture of cytokine activation in cardiac surgery, a combination of cytokines and the corresponding soluble receptor concentration should be determined. Blood samples were collected from the radial artery and coronary sinus perioperatively in ten patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. TNF-alpha, IL-6, sTNFRI, sTNFRII, and sIL-6R levels in the plasma were determined. Systemic TNFRI, TNFRII and IL-6 increased significantly after reperfusion to the myocardium, while perioperative systemic sIL-6r levels were similar. Arterial and sinus levels of TNFRI, TNFRII and sIL-6r were similar before cardiopulmonary bypass. Five minutes after reperfusion to the myocardium, higher sinus TNFRI and TNFRII and lower sinus sIL-6R levels were observed as compared to the arterial levels. The myocardium release of sTNFRI (r=0.57, P=0.089) and sTNFRII (r=0.64, P=0.047) positively correlated with the change of cardiac index after cardiopulmonary bypass. Myocardium releases sTNFRI and sTNFRII after ischaemic-reperfusion injury, and this may be of benefit to cardiac performance. sIL-6R is constantly being produced in areas other than the myocardium, while sIL-6R levels are reduced by consumption in the myocardium after ischaemic-reperfusion injury. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563882     DOI: 10.1006/cyto.2001.0920

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Attenuated recovery of contractile function in aging hearts following global ischemia/reperfusion: Role of extracellular HSP27 and TLR4.

Authors:  Lihua Ao; Yufeng Zhai; Chunhua Jin; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Mol Med       Date:  2016-12-19       Impact factor: 6.354

Review 2.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

3.  Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation.

Authors:  Rachael L Ford; Ira M Mains; Ebony J Hilton; Scott T Reeves; Robert E Stroud; Fred A Crawford; John S Ikonomidis; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2008-11       Impact factor: 4.330

4.  Relation of cytokines to vasodilation after coronary artery bypass grafting.

Authors:  Minxin Wei; Pekka Kuukasjärvi; Jari Laurikka; Seppo Kaukinen; Eva-Liisa Honkonen; Riina Metsänoja; Matti Tarkka
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

5.  Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].

Authors:  Cornelia W Hoedemaekers; Peter Pickkers; Mihai G Netea; Marcel van Deuren; Johannes G Van der Hoeven
Journal:  Crit Care       Date:  2005-11-16       Impact factor: 9.097

6.  In vivo immune signatures of healthy human pregnancy: Inherently inflammatory or anti-inflammatory?

Authors:  Caroline Graham; Rishma Chooniedass; William P Stefura; Allan B Becker; Malcolm R Sears; Stuart E Turvey; Piush J Mandhane; Padmaja Subbarao; Kent T HayGlass
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

7.  Characteristics of Interleukin-6 Signaling in Elective Cardiac Surgery-A Prospective Cohort Study.

Authors:  Jürgen Puchinger; Sylvia Ryz; Larissa Nixdorf; Maximilian Edlinger-Stanger; Andrea Lassnigg; Dominik Wiedemann; Michael Hiesmayr; Andreas Spittler; Martin H Bernardi
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.